Elevance Health, Inc. (ELV)
NYSE: ELV · Real-Time Price · USD
389.22
+3.93 (1.02%)
Jan 21, 2025, 4:00 PM EST - Market closed
Elevance Health Employees
Elevance Health had 104,900 employees as of December 31, 2023. The number of employees increased by 2,600 or 2.54% compared to the previous year.
Employees
104,900
Change (1Y)
2,600
Growth (1Y)
2.54%
Revenue / Employee
$1,658,866
Profits / Employee
$61,182
Market Cap
90.27B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 104,900 | 2,600 | 2.54% |
Dec 31, 2022 | 102,300 | 4,100 | 4.18% |
Dec 31, 2021 | 98,200 | 14,800 | 17.75% |
Dec 31, 2020 | 83,400 | 12,800 | 18.13% |
Dec 31, 2019 | 70,600 | 6,700 | 10.49% |
Dec 31, 2018 | 63,900 | 7,900 | 14.11% |
Dec 31, 2017 | 56,000 | 3,000 | 5.66% |
Dec 31, 2016 | 53,000 | 0 | - |
Dec 31, 2015 | 53,000 | 1,500 | 2.91% |
Dec 31, 2014 | 51,500 | 3,300 | 6.85% |
Dec 31, 2013 | 48,200 | 4,700 | 10.80% |
Dec 31, 2012 | 43,500 | 5,800 | 15.38% |
Dec 31, 2011 | 37,700 | 200 | 0.53% |
Dec 31, 2010 | 37,500 | -3,000 | -7.41% |
Dec 31, 2009 | 40,500 | -2,400 | -5.59% |
Dec 31, 2008 | 42,900 | 1,200 | 2.88% |
Dec 31, 2007 | 41,700 | -300 | -0.71% |
Dec 31, 2006 | 42,000 | 0 | - |
Dec 31, 2005 | 42,000 | 4,000 | 10.53% |
Dec 31, 2004 | 38,000 | 17,870 | 88.77% |
Dec 31, 2003 | 20,130 | 630 | 3.23% |
Dec 31, 2002 | 19,500 | 4,700 | 31.76% |
Dec 31, 2001 | 14,800 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
ELV News
- 7 hours ago - Mark Farrah Associates Delves into Acquisition Impacts Utilizing New Tools - Business Wire
- 12 days ago - Elevance Health to Hold Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2024 Results on January 23, 2025 - Business Wire
- 18 days ago - My Top 15 High Growth Dividend Stocks For January 2025 - Seeking Alpha
- 26 days ago - Elevance Health Is An Undervalued Healthcare Juggernaut - Seeking Alpha
- 5 weeks ago - Santa's Stunning Stocking Surprises: 5 High Yield Blue-Chip Bargains For 2025 - Seeking Alpha
- 5 weeks ago - Robbins LLP Informs Elevance Health Inc. Stockholders that it is Investigating the Officers and Directors of ELV to Determine if They Breached Fiduciary Duties Owed to Shareholders - GlobeNewsWire
- 5 weeks ago - Health care stocks fall as lawmakers, patients push for changes to their business models - CNBC
- 5 weeks ago - Health insurer stocks fall as WSJ says lawmakers set to break up pharmacy-benefit managers - Reuters